These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38970464)

  • 1. Detection of colorectal-cancer-associated bacterial taxa in fecal samples using next-generation sequencing and 19 newly established qPCR assays.
    Senthakumaran T; Tannæs TM; Moen AEF; Brackmann SA; Jahanlu D; Rounge TB; Bemanian V; Tunsjø HS
    Mol Oncol; 2024 Jul; ():. PubMed ID: 38970464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal
    Shen X; Li J; Li J; Zhang Y; Li X; Cui Y; Gao Q; Chen X; Chen Y; Fang JY
    Front Oncol; 2021; 11():661048. PubMed ID: 34046355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
    Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
    Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study.
    Russo E; Bacci G; Chiellini C; Fagorzi C; Niccolai E; Taddei A; Ricci F; Ringressi MN; Borrelli R; Melli F; Miloeva M; Bechi P; Mengoni A; Fani R; Amedei A
    Front Microbiol; 2017; 8():2699. PubMed ID: 29375539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the abundance of
    Xu J; Yang M; Wang D; Zhang S; Yan S; Zhu Y; Chen W
    Oncol Lett; 2020 Oct; 20(4):106. PubMed ID: 32831925
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers.
    Mira-Pascual L; Cabrera-Rubio R; Ocon S; Costales P; Parra A; Suarez A; Moris F; Rodrigo L; Mira A; Collado MC
    J Gastroenterol; 2015 Feb; 50(2):167-79. PubMed ID: 24811328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis.
    Mo S; Wang H; Han L; Xiang W; Dai W; Zhao P; Pei F; Su Z; Ma C; Li Q; Wang Z; Cai S; Wang H; Liu R; Cai G
    Front Oncol; 2021; 11():643136. PubMed ID: 33718241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.
    Thomas AM; Jesus EC; Lopes A; Aguiar S; Begnami MD; Rocha RM; Carpinetti PA; Camargo AA; Hoffmann C; Freitas HC; Silva IT; Nunes DN; Setubal JC; Dias-Neto E
    Front Cell Infect Microbiol; 2016; 6():179. PubMed ID: 28018861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput qPCR and 16S rRNA gene amplicon sequencing as complementary methods for the investigation of the cheese microbiota.
    Dreier M; Meola M; Berthoud H; Shani N; Wechsler D; Junier P
    BMC Microbiol; 2022 Feb; 22(1):48. PubMed ID: 35130830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
    Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the structure of intestinal mucosal flora in colorectal cancer patients].
    Hu M; Chen K; Wang N; Zhao Y; Wei C; Meng L; Tang Y; Teng Y; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):263-271. PubMed ID: 35365452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections.
    Malik SA; Zhu C; Li J; LaComb JF; Denoya PI; Kravets I; Miller JD; Yang J; Kramer M; McCombie WR; Robertson CE; Frank DN; Li E
    World J Gastroenterol; 2021 Apr; 27(14):1465-1482. PubMed ID: 33911468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches.
    Galazzo G; van Best N; Benedikter BJ; Janssen K; Bervoets L; Driessen C; Oomen M; Lucchesi M; van Eijck PH; Becker HEF; Hornef MW; Savelkoul PH; Stassen FRM; Wolffs PF; Penders J
    Front Cell Infect Microbiol; 2020; 10():403. PubMed ID: 32850498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.